Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.
Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.
复制标题
DOI:
10.1002/hep.23102
复制
发表时间:
2009-09
期刊:
影响因子:
13.5
通讯作者:
Brigstock, David R.
中科院分区:
文献类型:
--
作者:
Tong, ZhenYue;Chen, Ruju;Alt, Daniel S.;Kemper, Sherri;Perbal, Bernard;Brigstock, David R.
Connective tissue growth factor (CCN2) is a matricellular protein that is up-regulated in many fibrotic disorders and co-expressed with transforming growth factor beta. CCN2 promotes fibrogenesis and survival in activated hepatic stellate cells, and injured or fibrotic liver contains up-regulated levels of CCN2 which are produced by a variety of different cell types, including hepatocytes. To investigate CCN2 action in vivo, transgenic FVB mice were created in which the human CCN2 gene was placed under the control of the albumin enhancer promoter to elevate hepatocyte CCN2 levels. Production of hCCN2 mRNA and elevated CCN2 protein levels was demonstrated in transgenic livers, while levels of endogenous mouse CCN2 were comparable between transgenic and wild-type mice. Liver histology and liver function tests were unaffected in transgenic animals. However, after chronic administration of carbon tetrachloride (CCl4), alpha-smooth muscle actin (α-SMA)-expressing cells and collagen deposition were increased as a function of the dosage of the hCCN2 transgene (i.e. hccn2+/+ > hccn2+/- > hccn2-/-). Moreover, CCl4-induced serum hyaluronic acid, hepatic tissue levels of α-SMA or acid-soluble collagen, and mRNA expression of α-SMA, collagen α1 (I), matrix metalloprotease-2, or tissue inhibitor of metalloprotease-1 were greater in transgenic mice than in wild-type mice. Transgenic mice also exhibited enhanced hepatic deposition of collagen two weeks after bile duct ligation Conclusion: Production of elevated CCN2 levels in hepatocytes of transgenic mice in vivo does not cause hepatic injury or fibrosis per se but renders the livers more susceptible to the injurious actions of other fibrotic stimuli. These studies support for a central role of CCN2 in hepatic fibrosis and demonstrate a role of the micro-environment in regulating the pro-fibrotic action of CCN2.
登录
查看更多内容
影响因子:
4.1
作者:
Leask, Andrew;Chen, Shaoqiong;Brigstock, David R.
通讯作者:
Brigstock, David R.
影响因子:
9.3
作者:
Gressner, Axel M.;Yagmur, Eray;Stanzel, Sven
通讯作者:
Stanzel, Sven
影响因子:
29.4
作者:
Hillebrandt, S;Goos, C;Lammert, F
通讯作者:
Lammert, F
影响因子:
3.5
作者:
Hoshijima, M;Hattori, T;Takigawa, M
通讯作者:
Takigawa, M
DOI:
10.1016/j.biocel.2008.07.025
发表时间:
2009-04
影响因子:
4
作者:
Chen, Chih-Chiun;Lau, Lester F.
通讯作者:
Lau, Lester F.